Postoperative Management of Diabetes

  • Byron Unger
  • Douglas B. Coursin


Diabetes mellitus is the most commonly encountered endocrinopathy in surgical and critically ill patients. Patients with diabetes are more likely to require surgical procedures than patients who do not have diabetes, and the number of patients with the disease (mainly type 2) continues to rise as the population ages (1). Diabetes, which is a disease of glucose dysregulation and carbohydrate intolerance, can be classified into four major types: type 1 (insulin dependent), type 2 (non-insulin dependent), gestational, and secondary (See Table 1) (2). Diabetes may result in acute and long-term systemic sequelae (See Table 2).


Blood Glucose Level Autonomic Neuropathy Diabetic Ketoacidosis Oral Hypoglycemic Agent Regular Insulin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    PetersA, Kerner W. Perioperative management of the diabetic patient. Exp Clin Endocrinol Diabetes 1995; 103: 213–8.CrossRefGoogle Scholar
  2. 2.
    Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 (suppl 1): S5 - S19.Google Scholar
  3. 3.
    Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999; 341: 1749–56.PubMedCrossRefGoogle Scholar
  4. 4.
    Boulanger BR, Gann DS. Management of the trauma victim with pre-existing endocrine disease. Crit Care Clin 1994; 10: 537–54.PubMedGoogle Scholar
  5. 5.
    Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc 1996; 71: 801–12.PubMedCrossRefGoogle Scholar
  6. 6.
    Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 1992; 18: 187–201.PubMedGoogle Scholar
  7. 7.
    DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281–303.PubMedGoogle Scholar
  8. 8.
    Arem, R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am 1989; 18: 103–21.PubMedGoogle Scholar
  9. 9.
    Comi RJ. Approach to acute hypoglycemia. Endocrinol Metab Clin North Am 1993; 22: 247–62.PubMedGoogle Scholar
  10. 10.
    Fleckman AM. Diabetic ketoacidosis. Endocrinol Metab Clin North Am 1993; 22: 181–207.PubMedGoogle Scholar
  11. 11.
    Guerin JM, Meyer P, Segrestaa JM. Hypothermia in diabetic ketoacidosis. Diabetes Care 1987; 10: 801–2.PubMedGoogle Scholar
  12. 12.
    Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 1983; 117: 551–8.PubMedGoogle Scholar
  13. 13.
    Ellis EN. Concepts of fluid therapy in diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic coma. Pediatr Clin North Am 1990; 37: 313–21.PubMedGoogle Scholar
  14. 14.
    Katz MA. Hyperglycemia-induced hyponatremia: calculation of expected serum sodium depression. N Engl J Med 1973; 289: 843–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Riley LJ Jr, Cooper M, Narins RG. Alkali therapy of diabetic ketoacidosis: biochemical, physiologic, and clinical perspectives. Diabetes Metab Rev 1989; 5: 627–36.PubMedCrossRefGoogle Scholar
  16. 16.
    Viallon A, Zeni F, Lafond P, Venet C, Tardy B, Page Y, Bertrand JC. Does bicarbonate therapy improve the management of severe diabetic ketoacidosis?. Crit Care Med 1999; 27: 2690–3.PubMedCrossRefGoogle Scholar
  17. 17.
    Bello FA, Sotos JF. Cerebral oedema in diabetic ketoacidosis in children. Lancet 1990; 336: 64.PubMedCrossRefGoogle Scholar
  18. 18.
    Duck SC, Weldon VV, Pagliara AS, Haymond MW. Cerebral edema complicating therapy for diabetic ketoacidosis. Diabetes 1976; 25: 111–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990; 13: 22–33.PubMedCrossRefGoogle Scholar
  20. 20.
    Van der Meulen JA, Klip A, Grinstein S. Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet 1987; 2: 306–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabet Med 1993; 10: 282–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Matz R. Hyperosmolar nonacidotic diabetes (HNAD). In: Porte D, Sherwin RS, eds. Ellenberg & Rifkin’s Diabetes Mellitus, 5th ed., Stamford, CT: Appleton & Lange 1997: 850.Google Scholar
  23. 23.
    Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am 1995; 79: 39–52.PubMedGoogle Scholar
  24. 24.
    Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332: 1210–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127: 788–95.PubMedGoogle Scholar
  26. 26.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.Google Scholar
  27. 27.
    UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–65.Google Scholar
  28. 28.
    Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296–306.PubMedGoogle Scholar
  29. 29.
    Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489–97.PubMedCrossRefGoogle Scholar
  30. 30.
    Golan L, Birkmeyer JD, Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med 1999; 131: 660–7.PubMedGoogle Scholar
  31. 31.
    Hogan K, Rusy D, Springman SR. Difficult laryngoscopy and diabetes mellitus. Anesth Analg 1988; 67: 1162–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Byron Unger
    • 1
  • Douglas B. Coursin
    • 2
  1. 1.University of AlbertaEdmondCanada
  2. 2.University of WisconsinMadisonUSA

Personalised recommendations